154 related articles for article (PubMed ID: 632139)
1. Combination of radiation and razoxane (ICRF 159) in vivo.
Hellmann K; Grimshaw MB; Hutchinson GE
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):109-13. PubMed ID: 632139
[No Abstract] [Full Text] [Related]
2. A clinical evaluation of ICRF 159 as a radiosensitising agent.
Bates T
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):127-31. PubMed ID: 344288
[No Abstract] [Full Text] [Related]
3. Radiotherapy combined with ICRF 159 (NSC 129943).
Rhomberg WU
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):121-6. PubMed ID: 204615
[No Abstract] [Full Text] [Related]
4. Further evaluation of bimolane and analogs as potential antitumor agents.
Ren YF; Otter GM; Schmid FA
Eur J Cancer Clin Oncol; 1985 Apr; 21(4):493-7. PubMed ID: 3859415
[TBL] [Abstract][Full Text] [Related]
5. Effect of AT1727 on growth and metastasis of murine tumours.
Li XT; Hutchinson GE; Pym BA; Finch M; Hellmann K
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):283-7. PubMed ID: 6681774
[TBL] [Abstract][Full Text] [Related]
6. ICRF-159: current status and clinical prospects.
Bellet RE; Rozencweig M; Von Hoff DD; Penta JS; Wasserman TH; Muggia FM
Eur J Cancer (1965); 1977 Nov; 13(11):1293-8. PubMed ID: 590286
[No Abstract] [Full Text] [Related]
7. Radiotherapy and ICRF 159 in the treatment of soft tissue sarcomas.
Ryall RD
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):133-4. PubMed ID: 632140
[No Abstract] [Full Text] [Related]
8. [The influence of mecytosine on the antiblastic effect of radiation].
Vershinina SF; Maksimova OV
Vopr Onkol; 1972; 18(8):80-2. PubMed ID: 4348592
[No Abstract] [Full Text] [Related]
9. ICRF-159 enhancement of radiation response in combined modality therapies. I. Time/dose relationships for tumour response.
Kovacs CJ; Evans MJ; Schenken LL; Burholt DR
Br J Cancer; 1979 May; 39(5):516-23. PubMed ID: 486307
[TBL] [Abstract][Full Text] [Related]
10. Double blind controlled clinical trial of radiation plus razoxane (ICRF 159) versus radiation plus placebo in the treatment of head and neck cancer.
Bakowski MT; Macdonald E; Mould RF; Cawte P; Sloggem J; Barrett A; Dalley V; Newton KA; Westbury G; James SE; Hellmann K
Int J Radiat Oncol Biol Phys; 1978; 4(1-2):115-9. PubMed ID: 344287
[No Abstract] [Full Text] [Related]
11. Letter: Studies of the radiosensitizing action in vivo of 2,2,6,6, tetramethyl-4-piperidinol-N-oxyl (TMPN).
Hill RP; Fielden EM; Lillicrap SC; Stanley JA
Int J Radiat Biol Relat Stud Phys Chem Med; 1975 May; 27(5):499-501. PubMed ID: 168164
[No Abstract] [Full Text] [Related]
12. Effect of stereoisomers related to ICRF-159 on metastasis of B16 melanoma.
Zwilling BS; Campolito LB; Reiches NA; George T; Witiak DT
Br J Cancer; 1981 Oct; 44(4):578-83. PubMed ID: 7295515
[TBL] [Abstract][Full Text] [Related]
13. ICRF-159 enhancement of radiation response in combined modality therapies. II. Differential responses of tumour and normal tissues.
Kovacs CJ; Evans MJ; Burholt DR; Schenken LL
Br J Cancer; 1979 May; 39(5):524-30. PubMed ID: 486308
[TBL] [Abstract][Full Text] [Related]
14. Preliminary report on AT1727 as a potential radiosensitizer.
Zhang ZY; Liu TF; Zhang XF
Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2305-7. PubMed ID: 6392223
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potentiation of combined cis-dichlorodiammineplatinum (II) and irradiation by ICRF-159.
Kovacs CJ; Schenken LL; Burholt DR
Int J Radiat Oncol Biol Phys; 1979 Aug; 5(8):1361-4. PubMed ID: 575120
[No Abstract] [Full Text] [Related]
16. ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane.
Bakowski MT
Cancer Treat Rev; 1976 Jun; 3(2):95-107. PubMed ID: 821609
[No Abstract] [Full Text] [Related]
17. Enhancement of experimental lung metastases by cultured B16 melanoma cells treated with (+/-)-1,2-bis(3,5-dioxopiperazin-1-y)propane (ICRF-159).
Lazo JS; Ingber DE; Sartorelli AC
Cancer Res; 1978 Aug; 38(8):2263-70. PubMed ID: 667822
[No Abstract] [Full Text] [Related]
18. ICRF-187 in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
Cancer Clin Trials; 1981; 4(2):143-6. PubMed ID: 6788388
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization of pulmonary metastases-I. In vivo testing of hycanthone, insulin and razoxane.
Davies BM; Watling DC
Int J Radiat Oncol Biol Phys; 1979 Jun; 5(6):803-9. PubMed ID: 500411
[No Abstract] [Full Text] [Related]
20. Hypoxic cell radiosensitizers and local control by X-ray of a transplanted tumour in mice.
Sheldon PW; Hill SA
Br J Cancer; 1977 Jun; 35(6):795-808. PubMed ID: 871367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
